as amended (the “Development Agreement”), under which Saint-Gobain has agreed to develop a range of disposables for use in the Company’s automated production systems to be used for the manufacture of the Company’s Arcelis-based products. https://marketexclusive.com/argos-therapeutics-inc-nasdaqargs-files-an-8-k-entry-into-a-material-definitive-agreement-4/2017/11/